Showing results (31-40 of 194) with videos related to

Sort By:
Pageof 20
Gene Therapy|February 26, 2026
Cost-effectiveness of gene therapy for sickle cell disease in Uganda: tailoring high-income evidence to Uganda's contextJ Felipe Montano-Campos, Jennifer E Adair, Anirban Basu, et al.
The Journal of Infectious Diseases|September 27, 2024
Changes in the Lipidome Are Associated With Immune Activation and Subclinical Vascular Disease in Youth With Human Immunodeficiency Virus in UgandaSahera Dirajlal-Fargo, Melica Nikahd, Kate Ailstock, et al.
The Journal of Infectious Diseases|February 3, 2005
T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfectionMark P Eggena, Banson Barugahare, Martin Okello, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 27, 2018
Brief Report: Efficacy and Safety of Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (E/C/F/TAF) in Virologically Suppressed WomenSally Hodder, Kathleen Squires, Cissy Kityo, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|September 5, 2022
Sex-specific performance of the ASCVD pooled cohort equation risk calculator as a correlate of coronary artery calcium in Kampala, UgandaKatherine Kentoffio, Matthew S Durstenfeld, Mark J Siedner, et al.
Journal of Virology|March 16, 2005
Human immunodeficiency virus-specific responses in adult Ugandans: patterns of cross-clade recognitionBanson Barugahare, Chris Baker, Okumu K'Aluoch, et al.
Frontiers in Immunology|April 14, 2023
Persistent immune activation and altered gut integrity over time in a longitudinal study of Ugandan youth with perinatally acquired HIVSahera Dirajlal-Fargo, Monika Strah, Kate Ailstock, et al.
AIDS (London, England)|October 3, 2023
Factors associated with insulin resistance in a longitudinal study of Ugandan youth with and without HIVSahera Dirajlal-Fargo, Monika Strah, Kate Ailstock, et al.
Pageof 20